ELV
Elevance Health, Inc.
NYSE: ELV · Indianapolis, IN · Healthcare
$377.68-1.63 (-0.43%)Closed
Market Cap$81.90B
Cash$10.23Bmost recent
Runwayprofitable
P/E (TTM)15.0EPS $25.21
52-Wk Range$269.01 – $426.79
Avg Volume1.8M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$377.68-23.8%
Pipeline
Drug candidates sponsored by ELV · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for ELV. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.